@ShahidNShah
Why Aren’t We Using HIEs to Support Vaccination Efforts (and Everything Else)? w/ Niam Yaraghi - The #HCBiz Show
As of 2015 the Office of the National Coordinator for Health IT had awarded $548 million in grants to states to establish health information exchanges (HIE). I have no doubt hundreds of millions of dollars more have been invested in various ways since then. So, when faced with one of the most daunting healthcare data challenges of our time in the COVID-19 vaccine rollout, surely, we turned to the HIEs first. Right? Not so much, according to today’s guest.
Niam Yaraghi, assistant professor of Business Technology at Miami Herbert Business School at the University of Miami and a nonresident fellow at the Brookings Institution’s Center for Technology Innovation, recently explored the use of HIEs in vaccination efforts across the country. He tells us that “While the U.S. employed every possible resource to develop the vaccines, we are neglecting to use the best available information technologies to efficiently distribute them”.
In Yaraghi’s recent article, co-authored with Brookings Institution colleague Peter Levin, they share that none of the state vaccination plans they reviewed made any mention of using HIEs to support the effort. Further, they found no correlation between a state’s vaccination success and the existence of a robust HIE infrastructure in that state.
Continue reading at thehcbiz.com
Make faster decisions with community advice
- Going To The Molecular Level To Think Big About Cancer
- What Does Remote Patient Monitoring and Chronic Care Management Really Take to Be Successful?
- 5 Reasons Why You Need to Prioritize Prescription Price Transparency
- Improving Patient Outcomes Using Video Appointments
- Interstate Licensure For Telehealth Can Fuel Medical Practice Growth [PODCAST]
Next Article
-
5 Reasons Why You Need to Prioritize Prescription Price Transparency
New regulation requires that health systems list pricing for their most common 'shoppable' services. However, discrepancies in these prices are common, making many price transparency initiatives fall …
Posted Feb 26, 2021 Prescription drugs